Current Illinois CancerCare Clinical Trials

The Phase III `High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer

Study Number: GU013

Study Summary:
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.

Status: Open

RT Credentialing Pending

Study Coordinator(s)
  • Navigator Carrie, 309-243-3621
  • Drea, 309-243-3626

Study Link

« Search Again